Molecular photoacoustic imaging of follicular thyroid carcinoma

Clinical Cancer Research

Volumn 19, Issue 6, 2013, Pages 1494-1502

  Levi, Jelena ^a   Kothapalli, Sri Rajashekar ^a   Bohndiek, Sarah ^a   Yoon, Joon Kee ^b   Dragulescu Andrasi, Anca ^a   Nielsen, Carsten ^a   Tisma, Aleksandra ^c   Bodapati, Sunil ^a   Gowrishankar, Gayatri ^a   Yan, Xinrui ^a   Chan, Carmel ^a   Starcevic, Daniela ^a   Gambhir, Sanjiv Sam ^a  

^a STANFORD UNIVERSITY   (United States)

^b Ajou University School of Medicine   (South Korea)

^c Dom Zdravlja Novi Beograd   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXA750; CELL PENETRATING PEPTIDE; FLUORESCENT DYE; GELATINASE A; GELATINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE; LABORATORY DEVICE; MOLECULAR IMAGING; MOLECULAR PHOTOACOUSTIC IMAGING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PHOTOACOUSTIC PROBE; PHOTOACOUSTICS; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ANIMALS; CELL LINE, TUMOR; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MOLECULAR IMAGING; PHOTOACOUSTIC TECHNIQUES;

EID: 84875180212     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3061     Document Type: Article

References (26)

1. SEER Cancer Statistics Review 1975-2009 [cited 2012 Oct 10]. Available from: http://seer.cancer.gov/csr/1975-2009-pops09/results-merged/sect-26- thyroid.pdf.
2. Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002;235:656-62; discussion 62-4.
3. Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 2007;13:183-91.
4. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17: 545-80.
5. Li C, Wang LV. Photoacoustic tomography and sensing in biomedicine. Phys Med Biol 2009;54:R59-97.
6. Cho Mar K, Eimoto T, Tateyama H, Arai Y, Fujiyoshi Y, Hamaguchi M. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions. Histopathology 2006;48:286-94.
7. Buergy D, Weber T, Maurer GD, Mudduluru G, Medved F, Leupold JH, et al. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Int J Cancer 2009;125:894-901.
8. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295: 2387-92.
9. Omi Y, Shibata N, Okamoto T, Obara T, Kobayashi M. The role of CD147 in the invasiveness of follicular thyroid carcinoma cells. Thyroid 2012;22:383-94.
10. Kraiem Z, Korem S. Matrix metalloproteinases and the thyroid. Thyroid 2000;10:1061-9.
11. Levi J, Kothapalli SR,MaTJ, Hartman K, Khuri-Yakub BT, Gambhir SS. Design, synthesis, and imaging of an activatable photoacoustic probe. J Am Chem Soc 2010;132:11264-9.
12. Kobayashi H, Choyke PL. Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res 2011;44:83-90.
13. Aguilera TA, Olson ES, TimmersMM, Jiang T, Tsien RY. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. Integr Biol (Camb) 2009;1: 371-81.
14. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003;2:131-7.
15. Baldini E, Toller M, Graziano FM, Russo FP, Pepe M, Biordi L, et al. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid 2004; 14:881-8.
16. Smith L MA, Capper SJ. Determination of species cross-reactivity using MMP-2 Activity Assay and correlation with ELISA and gelatin zymography. Life Science News 1999;3:1-2.
17. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 2004;101:17867-72.
18. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, et al. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) 2009;1: 382-93.
19. Razansky D, Harlaar NJ, Hillebrands JL, Taruttis A, Herzog E, Zeebregts CJ, et al. Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol Imaging Biol 2012;14:277-85.
20. van Duijnhoven SM, Robillard MS, Nicolay K, Grull H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med 2011;52:279-86.
21. Linder KE, Metcalfe E, Nanjappan P, Arunachalam T, Ramos K, Skedzielewski TM, et al. Synthesis, in vitro evaluation, and in vivo metabolism of fluor/quencher compounds containing IRDye 800CW and Black Hole Quencher-3 (BHQ-3). Bioconjug Chem 2011;22:1287-97.
22. Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, et al. Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem 2009;52:358-68.
23. Jokerst JV, Thangaraj M, Kempen PJ, Sinclair R, Gambhir SS. Photoacoustic imaging of mesenchymal stem cells in living mice via silicacoated gold nanorods. ACS Nano 2012;6:5920-30.
24. Homan KA, Souza M, Truby R, Luke GP, Green C, Vreeland E, et al. Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano 2012;6:641-50.
25. Li W, Brown PK, Wang LV, Xia Y. Gold nanocages as contrast agents for photoacoustic imaging. Contrast Media Mol Imaging 2011;6: 370-7.
26. de la Zerda A, Bodapati S, Teed R, May SY, Tabakman SM, Liu Z, et al. Family of enhanced photoacoustic imaging agents for highsensitivity and multiplexing studies in living mice. ACS Nano 2012;6:4694-701.